{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:00:52Z","timestamp":1790341252087,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.omton.2026.201345","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:22:48Z","timestamp":1790338968000},"page":"201345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the tumor, harboring the host: IL-7 receptor-targeted CARs to treat T-ALL"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1329-4736","authenticated-orcid":false,"given":"Valeriya","family":"Kuznetsova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi K.","family":"Kothuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1699-2046","authenticated-orcid":false,"given":"Prasad S.","family":"Adusumilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6406-3565","authenticated-orcid":false,"given":"Alfredo","family":"Amador-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201345_bib1","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41375-018-0065-5","article-title":"An \u201coff-the-shelf\u201d fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies","volume":"32","author":"Cooper","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.omton.2026.201345_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-75675-5","article-title":"IL7-receptor-targeted CAR T-cell therapy for T-cell acute lymphoblastic leukemia","volume":"17","author":"Hocine","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201345_bib3","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1182\/blood.2019000553","article-title":"Overexpression of wild-type IL-7Ralpha promotes T-cell acute lymphoblastic leukemia\/lymphoma","volume":"138","author":"Silva","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.omton.2026.201345_bib4","first-page":"158","article-title":"IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition","volume":"142","author":"Courtois","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.omton.2026.201345_bib5","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","article-title":"Tumor antigen escape from CAR T-cell therapy","volume":"8","author":"Majzner","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2026.201345_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41392-022-00898-z","article-title":"T cells expressing CD5\/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape","volume":"7","author":"Dai","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.omton.2026.201345_bib7","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.4049\/jimmunol.180.8.5201","article-title":"Differential regulation of human IL-7 receptor alpha expression by IL-7 and TCR signaling","volume":"180","author":"Alves","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2026.201345_bib8","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1158\/0008-5472.CAN-15-0159","article-title":"Affinity-tuned ErbB2 or EGFR chimeric antigen receptor T cells exhibit an increased therapeutic index against tumors in mice","volume":"75","author":"Liu","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2026.201345_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13045-021-01178-z","article-title":"CAR T cells targeting CD99 as an approach to eradicate T-cell acute lymphoblastic leukemia without normal blood cells toxicity","volume":"14","author":"Shi","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.omton.2026.201345_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJMoa2505478","article-title":"Universal base-edited CAR7 T cells for T-cell acute lymphoblastic leukemia","volume":"394","author":"Chiesa","year":"2026","journal-title":"N. Engl. J. Med."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926002213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926002213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:22:50Z","timestamp":1790338970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926002213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2950329926002213"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201345","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the tumor, harboring the host: IL-7 receptor-targeted CARs to treat T-ALL","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201345"}}